Nutraceutical International Corporation

Nutraceutical International Corporation manufactures branded nutritional supplements and other natural products. The Company is known in the industry as a “vertically integrated”. This means that for each product, Nutraceutical strives to cover the entire process of manufacturing, marketing, distributing, and selling that product – from beginning to end – from as close to the farm or ocean or plant as they can get.

Type
Subsidiary
Parent Company
HGGC
HQ
Park City, US
Founded
1993
Nutraceutical International Corporation was founded in 1993 and is headquartered in Park City, US

Nutraceutical International Corporation Office Locations

Nutraceutical International Corporation has an office in Park City
Park City, US (HQ)
1400 Kearns Blvd

Nutraceutical International Corporation Data and Metrics

Nutraceutical International Corporation Summary

Founding Date

1993
Nutraceutical International Corporation is a subsidiary of HGGC

Nutraceutical International Corporation Financial Metrics

Nutraceutical International Corporation's revenue was reported to be $61.2 m in Q2, 2017
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

208.4 m214.5 m216.5 m233 m

Revenue growth, %

3%1%8%

Cost of goods sold

105.5 m108.2 m110.3 m114.9 m

Gross profit

102.9 m106.3 m106.2 m118 m

Gross profit Margin, %

49%50%49%51%

Operating expense total

74.7 m79.8 m81.9 m88.9 m

EBIT

28.1 m26.5 m24.3 m29.2 m

EBIT margin, %

13%12%11%13%

Pre tax profit

26.8 m25.1 m23.2 m27.9 m

Income tax expense

9.8 m9.2 m8 m9.3 m

Net Income

17 m15.9 m15.3 m18.7 m
USDQ3, 2014Q1, 2014Q2, 2015Q3, 2015Q1, 2015Q2, 2016Q3, 2016Q1, 2016Q2, 2017

Revenue

55.6 m53 m55.4 m54.4 m56 m59.5 m60.8 m56.6 m61.2 m

Cost of goods sold

28.5 m27.2 m28.1 m28 m27.9 m29.2 m29.4 m27.7 m30.1 m

Gross profit

27.2 m25.9 m27.3 m26.4 m28.1 m30.3 m31.4 m28.9 m31.1 m

Gross profit Margin, %

49%49%49%49%50%51%52%51%51%

General and administrative expense

19.8 m19.6 m19.8 m19.1 m20.3 m21.8 m21.9 m21.3 m23 m

Operating expense total

19.8 m19.6 m19.8 m19.1 m20.3 m21.8 m21.9 m21.3 m23 m

EBIT

6.7 m5.6 m6.7 m6.6 m6.8 m7.6 m8.5 m6.8 m7.2 m

EBIT margin, %

12%10%12%12%12%13%14%12%12%

Pre tax profit

6.3 m5.3 m6.5 m6.4 m6.5 m7.2 m8.2 m6.4 m6.8 m

Income tax expense

2.3 m1.9 m2.4 m1.9 m2.3 m2.6 m2.2 m2.2 m2.4 m

Net Income

4 m3.4 m4.1 m4.5 m4.2 m4.6 m6 m4.2 m4.5 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

8.2 m6.2 m4.6 m6.8 m

Accounts Receivable

13.7 m15.1 m16.8 m17.7 m

Inventories

49.3 m57.9 m59.4 m63.9 m

Current Assets

75 m83.9 m86.2 m93.9 m

PP&E

76.2 m79.2 m77.6 m83 m

Goodwill

15.8 m23.6 m24.4 m30.9 m

Total Assets

192.3 m214.8 m212.4 m235.9 m

Accounts Payable

14.3 m14.9 m14 m12.7 m

Total Debt

43.5 m

Current Liabilities

21.8 m21.7 m20.5 m20.2 m

Total Liabilities

63.9 m

Additional Paid-in Capital

15.1 m11.1 m7 m52 k

Retained Earnings

122.5 m138.3 m153.6 m172.3 m

Total Equity

137.9 m149.6 m160.2 m172 m

Debt to Equity Ratio

0.3 x

Debt to Assets Ratio

0.2 x

Financial Leverage

1.4 x1.4 x1.3 x1.4 x
USDQ3, 2014Q1, 2014Q2, 2015Q3, 2015Q1, 2015Q2, 2016Q3, 2016Q1, 2016Q2, 2017

Cash

5.1 m3.9 m5.2 m4.9 m5.3 m4.2 m3.6 m6.3 m6.1 m

Accounts Receivable

14.7 m15.1 m16.8 m14.2 m18.4 m19.3 m20.6 m18 m20.6 m

Inventories

55.8 m57 m56.8 m59.3 m61.8 m61.5 m63.9 m65.9 m65.3 m

Current Assets

80.1 m80.7 m83 m82.4 m90.6 m89.8 m92.7 m95.7 m97 m

PP&E

79.3 m79.9 m78.7 m78.4 m77.9 m83.5 m83.4 m82.3 m82.2 m

Goodwill

23.5 m23.6 m23.6 m24.4 m30.9 m30.9 m30.9 m30.9 m30.9 m

Total Assets

211.7 m211.9 m212.2 m210.9 m229.2 m234.5 m236.6 m236.2 m236.6 m

Accounts Payable

15.1 m12.6 m14 m14.2 m13.2 m13.9 m14.1 m15.7 m15.2 m

Current Liabilities

22.4 m17.4 m19.1 m20.1 m17.7 m20.7 m21.2 m20.4 m20.1 m

Common Stock

97 k97 k96 k96 k95 k94 k93 k93 k93 k

Additional Paid-in Capital

12.6 m10.5 m9.3 m8.5 m5.9 m4 m1.3 m1.5 m1.8 m

Retained Earnings

134.9 m141.7 m145.8 m150.2 m157.9 m162.5 m168.5 m175.3 m178.6 m

Total Equity

147.6 m152.2 m154.9 m158.7 m163.4 m166.1 m169.2 m176.3 m180 m

Financial Leverage

1.4 x1.4 x1.4 x1.3 x1.4 x1.4 x1.4 x1.3 x1.3 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

17 m15.9 m15.3 m18.7 m

Depreciation and Amortization

2.2 m2.7 m2.9 m3.9 m

Accounts Receivable

10 k(758 k)(1.6 m)458 k

Inventories

(2.6 m)(6.7 m)(1.5 m)(1.7 m)

Accounts Payable

1.5 m9 k(604 k)(1.4 m)

Cash From Operating Activities

26.8 m20 m25 m32.8 m

Purchases of PP&E

(8.3 m)(11.3 m)(8.6 m)(9 m)

Cash From Investing Activities

(11.7 m)(27.7 m)(9.8 m)(35.2 m)

Cash From Financing Activities

(11.6 m)5.7 m(16.6 m)4.6 m
USDQ3, 2014Q1, 2014Q2, 2015Q3, 2015Q1, 2015Q2, 2016Q3, 2016Q1, 2016Q2, 2017

Net Income

4 m3.4 m4.1 m4.5 m4.2 m4.6 m6 m4.2 m4.5 m

Depreciation and Amortization

704 k732 k728 k729 k981 k999 k988 k918 k908 k

Accounts Receivable

14.7 m15.1 m16.8 m14.2 m18.4 m19.3 m20.6 m18 m20.6 m

Inventories

55.8 m57 m56.8 m59.3 m61.8 m61.5 m63.9 m65.9 m65.3 m

Accounts Payable

15.1 m12.6 m14 m14.2 m13.2 m13.9 m14.1 m15.7 m15.2 m

Nutraceutical International Corporation Operating Metrics

FY, 2015

Trademarks

340

Traffic Overview of Nutraceutical International Corporation

Nutraceutical International Corporation Company Life and Culture

You may also be interested in